No profile data available.
Dyadic International, Inc. (DYAI) is a healthcare company in the laboratory analysis services industry, based in Jupiter, United States, with about 5 full-time employees.
It reported revenue of $1.23 million for fiscal year 2025, down 64.7% from fiscal year 2024, and net income of -$7.36 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $623,590, up 240.6% from a year before. United States was its largest region in fiscal year 2025, with 67% of revenue. Its market capitalization was $17.79 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
Dyadic International reported $1.23 million in revenue for fiscal year 2025, down 64.7% from $3.50 million in fiscal year 2024. In Q1 2026 revenue was $623,590.
United States: 67% of revenue by region in fiscal year 2025, followed by Europe and Asia (33%).
$17.79 million as of October 9, 2026.
Listed companies of a similar size in the same industry (laboratory analysis services) include Personalis, Inc. (PSNL), Azenta, Inc. (AZTA), Ginkgo Bioworks Holdings, Inc. (DNA).